AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Glyphmet M1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Biotics Lab Life Services Private Limited

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glyphmet M1 Tablet SR

Diabexe Duo SR tablets are a dual-action antidiabetic medication used in adult patients with type 2 diabetes. This combination therapy helps regulate blood glucose. Diabexe Duo SR should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is just one component of a comprehensive diabetes management plan, incorporating a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect, manifesting as sweating, dizziness, headache, and tremors. Prompt glucose intake (e.g., sugary foods or juice) is essential. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is also a potential consequence. Diabexe Duo SR is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring, along with periodic blood tests to evaluate blood cell counts and liver function, are recommended.

Primary Ingredients of Glyphmet M1 Tablet SR

No text provided to rephrase.

Uses of Glyphmet M1 Tablet SR

Managing Type 2 Diabetes

Major Benefits of Glyphmet M1 Tablet SR:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glyphmet M1 SR tablets should be administered with a meal.

Common Side effects of Glyphmet M1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glyphmet M1 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Glyphmet M1 Tablet SR should be administered with a meal.

How Glyphmet M1 Tablet SR works:

Glyphmet M1 SR tablets contain glimepiride and metformin, two medications that manage blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin, a biguanide, functions by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness in the body.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glyphmet M1 Tablet SR is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glyphmet M1 SR tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the unborn child. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glyphmet M1 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glyphmet M1 Tablet SR, potentially requiring dosage modification. Physician consultation is advised. Glyphmet M1 Tablet SR is contraindicated in patients with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Glyphmet M1 Tablet SR cautiously, potentially requiring dosage modification. Consult a physician for guidance. A reduced starting dose is typically advised for those with mild to moderate liver disease; the medication is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glyphmet M1 Tablet SR :

Should you forget a Glyphmet M1 Tablet SR dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Glyphmet M1 Tablet SR

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glyphmet M1 Tablet SR

Store this medication in its original, tightly sealed container or packaging, following all storage instructions provided on the label. Discard any leftover medication appropriately. Ensure it remains inaccessible to children, pets, and other individuals.
Lactic acidosis, a serious medical condition resulting from excessive blood lactic acid, is a potential adverse effect of Glyphmet M1 Tablet SR. This complication, also termed Metformin-associated lactic acidosis (MALA), though uncommon, poses a significant risk to individuals with pre-existing kidney impairment, the elderly, or those who consume substantial alcohol. Characteristic symptoms include muscle aches or weakness, lightheadedness, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal discomfort, and bradycardia. Should these symptoms appear, discontinue Glyphmet M1 Tablet SR and seek immediate medical attention.
Glyciphage M1 Extended-Release tablets contain glimepiride and metformin, two medications used together to manage type 2 diabetes. This dual-drug therapy helps control blood sugar in adults when combined with a healthy diet and regular physical activity. Glimepiride enhances insulin secretion from the pancreas, thereby reducing blood glucose. Metformin acts by decreasing hepatic glucose production and increasing cellular insulin responsiveness. This formulation is unsuitable for treating type 1 diabetes.
Taking Glyphmet M1 Tablet SR may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal discomfort, diarrhea, and headache. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged use can result in vitamin B12 deficiency.
Prolonged Glyphmet M1 Tablet SR use can indeed lead to Vitamin B12 deficiency due to impaired intestinal Vitamin B12 absorption. This deficiency, if left unaddressed, may result in anemia, neurological complications such as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and ataxia. Consequently, supplementary Vitamin B12 intake, at a minimum of once annually, is recommended by some studies to mitigate these risks.
Indeed, Glyphmet M1 Tablet SR can lead to hypoglycemia, characterized by low blood glucose. Manifestations of low blood sugar may encompass nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of unease or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice, is recommended.
Consuming alcohol concurrently with Glyphmet M1 Tablet SR is unsafe due to the risk of significantly reduced blood glucose, potentially causing hypoglycemia. Furthermore, this combination elevates the likelihood of lactic acidosis.
Glyphmet M1 Tablet SR
56
MRP 68
17% off